Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.
Winhusen T, Walley A, Fanucchi LC, Hunt T, Lyons M, Lofwall M, Brown JL, Freeman PR, Nunes E, Beers D, Saitz R, Stambaugh L, Oga EA, Herron N, Baker T, Cook CD, Roberts MF, Alford DP, Starrels JL, Chandler RK. Winhusen T, et al. Drug Alcohol Depend. 2020 Dec 1;217:108325. doi: 10.1016/j.drugalcdep.2020.108325. Epub 2020 Oct 4. Drug Alcohol Depend. 2020. PMID: 33091842 Free PMC article.
The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices.
HEALing Communities Study Consortium. HEALing Communities Study Consortium. Drug Alcohol Depend. 2020 Dec 1;217:108335. doi: 10.1016/j.drugalcdep.2020.108335. Epub 2020 Oct 17. Drug Alcohol Depend. 2020. PMID: 33248391 Free PMC article.
Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
Winhusen T, Wilder C, Lyons MS, Theobald J, Kropp F, Lewis D. Winhusen T, et al. Drug Alcohol Depend. 2020 Nov 1;216:108265. doi: 10.1016/j.drugalcdep.2020.108265. Epub 2020 Aug 31. Drug Alcohol Depend. 2020. PMID: 32919098 Free PMC article. Clinical Trial.
Exploring longitudinal course and treatment-baseline severity interactions in secondary outcomes of smoking cessation treatment in individuals with attention-deficit hyperactivity disorder.
Luo SX, Wall M, Covey L, Hu MC, Scodes JM, Levin FR, Nunes EV, Winhusen T. Luo SX, et al. Among authors: winhusen t. Am J Drug Alcohol Abuse. 2018;44(6):653-659. doi: 10.1080/00952990.2017.1416474. Epub 2018 Jan 25. Am J Drug Alcohol Abuse. 2018. PMID: 29370538 Free PMC article. Clinical Trial.
Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations.
Winhusen T, Lofwall M, Jones HE, Wilder C, Lindblad R, Schiff DM, Wexelblatt S, Merhar S, Murphy SM, Greenfield SF, Terplan M, Wachman EM, Kropp F, Theobald J, Lewis M, Matthews AG, Guille C, Silverstein M, Rosa C. Winhusen T, et al. Contemp Clin Trials. 2020 Jun;93:106014. doi: 10.1016/j.cct.2020.106014. Epub 2020 Apr 27. Contemp Clin Trials. 2020. PMID: 32353544 Free PMC article.
127 results